A Dose Escalating Study of HC002 in Healthy Adult Volunteers
Status:
COMPLETED
Trial end date:
2025-05-07
Target enrollment:
Participant gender:
Summary
This is a first-in-human (FIH) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of single and multiple ascending oral doses of HC002 in healthy adult participants.